| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 7355-55-7 | 2-氨基-4-羥基吡咯并[2,3-d]嘧啶 | 2-Amino-4-hydroxypyrrolo[2,3-d]pyrimidine; 7-Deazaguanine |  | C6H6N4O | 詳情 | 供應(yīng)商 |
| 110862-48-1 | 阿伐他汀; 阿托伐他汀; (3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲�；�)-5-異丙基吡咯-1-基]-3,5-二羥基? | Atorvastatin; (3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid |  | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
| 125995-03-1 | 阿托伐他汀內(nèi)酯; (4R,6R)-6-{2-[2-(4-氟苯基)-5-異丙基-3-苯基-4-(苯基氨基甲�；�)吡咯-1-基]乙基}-4-羥基四 | Atorvastatin lactone; (4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one |  | C33H33FN2O4 | 詳情 | 供應(yīng)商 |
| 134523-00-5 | 阿伐他汀; 阿托伐他汀; (3R,5R)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲酰基)-5-異丙基-吡咯-1-基]-3,5-二羥基 | Atorvastatin; (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid |  | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
| 148016-81-3 | 多尼培南; (+)-(4R,5S,6S)-6-[(1R)-1-羥基乙基]-4-甲基-7-氧代-3-[[(3S,5S)-5-[(氨基磺酰氨基)-甲基]-3-吡咯 | Doripenem; (+)-(4R,5S,6S)-6-[(1R)-1-Hydro-xyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)-methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |  | C15H24N4O6S2 | 詳情 | 供應(yīng)商 |
| 148214-90-8 | 反式-3-氨基-1-Boc-4-羥基吡咯烷; (3R,4R)-3-氨基-4-羥基吡咯烷-1-甲酸叔丁酯 | trans-3-Amino-1-Boc-4-hydroxypyrrolidine; (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate |  | C9H18N2O3 | 詳情 | 供應(yīng)商 |
| 190792-74-6 | (3S,4S)-N-Boc-3-氨基-4-羥基吡咯烷; (3S,4S)-3-氨基-4-羥基吡咯烷-1-甲酸叔丁酯 | (3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine; (3S,4S)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate; (3S,4S)-3-Amino-4-hydroxypyrrolidine-1-carboxylic acid tert-butyl ester |  | C9H18N2O3 | 詳情 | 供應(yīng)商 |
| 192726-06-0 | N-(4-氨基-1-芐基-3-羥基-5-苯基戊基)-3-甲基-2-(2-氧代四氫嘧啶-1-基)-丁酰胺5-氧代吡咯烷-2-甲酸 | N-(4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-buty |  | C27H38N4O3.C5H7NO3 | 詳情 | 供應(yīng)商 |
| 252574-03-1 | (3S,4S)-N-Boc-3-芐氨基-4-羥基吡咯烷; (3S,4S)-3-芐氨基-4-羥基吡咯烷-1-甲酸叔丁酯 | (3S,4S)-N-Boc-3-(benzylamino)-4-hydroxypyrrolidine; (3S,4S)-tert-Butyl 3-(benzylamino)-4-hydroxypyrrolidine-1-carboxylate; (3S,4S)-3-Hydroxy-4-[(phenylmethyl)amino]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester |  | C16H24N2O3 | 詳情 | 供應(yīng)商 |
| 274901-16-5 | 維達(dá)列汀; 維他列汀; (-)-(2S)-1-[[(3-羥基三環(huán)[3.3.1.1[3,7]]硅烷-1-基)氨基]乙�；鵠吡咯烷-2-甲腈 | vildagliptin; 2-Pyrrolidinecarbonitrile,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI); Galvus; LAF 237; NVP-LAF 237; Vildagliptin |  | C17H25N3O2 | 詳情 | 供應(yīng)商 |
| 429673-83-6 | (3R,4R)-N-Boc-3-芐氨基-4-羥基吡咯烷; (3R,4R)-3-芐氨基-4-羥基吡咯烷-1-甲酸叔丁酯 | (3R,4R)-N-Boc-3-(benzylamino)-4-hydroxypyrrolidine; (3R,4R)-tert-Butyl 3-(benzylamino)-4-hydroxypyrrolidine-1-carboxylate; (3R,4R)-3-Hydroxy-4-[(phenylmethyl)amino]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester |  | C16H24N2O3 | 詳情 | 供應(yīng)商 |
| 111821-58-0 | (-)-3-氨基-1-羥基-2-吡咯酮 | 2-Pyrrolidinone,3-amino-1-hydroxy-, (3S)-; 2-Pyrrolidinone,3-amino-1-hydroxy-, (S)-; (-)-HA 966; (S)-HA 966 |  | C4H8N2O2 | 詳情 | 供應(yīng)商 |
| 123931-04-4 | R(+)-3-氨基-1-羥基-2-吡咯烷酮 | 2-Pyrrolidinone,3-amino-1-hydroxy-, (3R)-; 2-Pyrrolidinone,3-amino-1-hydroxy-, (R)-; (+)-HA 966; (R)-(+)-HA 966; (R)-HA 966 |  | C4H8N2O2 | 詳情 | 供應(yīng)商 |
| 175463-34-0 | 4-BOC-氨基乙基-1-N-BOC-3-羥基吡咯烷; 4-BOC-氨基乙基-1-N-BOC-3-羥基吡咯烷; 4-叔丁氧羰基氨甲基-1-N-叔丁? | 4-BOC-AMINOMETHYL-3-HYDROXY-1-N-BOC-PYRROLIDINE |  | C15H28N2O5 | 詳情 | 供應(yīng)商 |
| 821794-92-7 | FMK; FMK; 1-[4-氨基-7-(3-羥基丙基)-5-(4-甲基苯基)-7H-吡咯并[2,3-D]嘧啶-6-基]-2-氟乙酮 | 1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone; 1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone; RSK2 kinase inhibitor |  | 詳情 | 供應(yīng)商 | |
| 1143532-39-1 | 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羥基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺; 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羥基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 | AZD5363; AZD5363; 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide; AZD5356 | 無 | C21H25ClN6O2 | 詳情 | 供應(yīng)商 |
| 1262849-73-9 | (3R,4S)-4-[[2-(5-氟-2-羥基苯基)-6,7-二甲氧基-4-喹唑啉基]氨基]-ALPHA,ALPHA-二甲基-3-吡咯烷甲醇; (3R,4S)-4-[[2-(5-氟-2-羥基苯基)-6,7-二甲氧基-4-喹唑啉基]氨基]-ALPHA,ALPHA-二甲基-3-吡咯烷甲醇 | CCT241533; CCT241533; (3R,4S)-4-[[2-(5-Fluoro-2-hydroxyphenyl)-6,7-dimethoxy-4-quinazolinyl]amino]-alpha,alpha-dimethyl-3-pyrrolidinemethanol | 無 | C23H27FN4O4 | 詳情 | 供應(yīng)商 |
| 905579-51-3 | 氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氫-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羥基環(huán)戊基]甲基酯; 氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氫-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羥基環(huán)戊基]甲基酯 | Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester; MLN 4924; Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester; ((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)aMino)-7H-pyrrolo[2,3-d]pyriMidin-7-yl)-2-hydroxycyclopentyl)Methyl sulfaMate; [(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]aMino}-7H-pyrrolo[2,3-d]pyriMidin-7-yl)-2-hydroxycyclopentyl]Methyl sulfaMate |  | C21H25N5O4S | 詳情 | 供應(yīng)商 |
| 120428-80-0 | 奧拉西坦進(jìn)口標(biāo)準(zhǔn)雜質(zhì)ISF3886; N-(2-氨基-2-氧代乙基)-2-(4-羥基-2-氧代四氫吡咯-1-基)乙酰胺; 奧拉西坦進(jìn)口標(biāo)準(zhǔn)雜質(zhì)ISF3886; 奧拉西坦雜質(zhì)5; 奧拉西坦相關(guān)物質(zhì)1 | oxiracetaM related substance ISF3886; N-(2-aMino-2-oxoethyl)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetaMide; oxiracetaM related substance ISF3886; OxiracetaM IMp. ISF3886; OxiracetaM Related CoMpound 1 | 無 | 詳情 | 供應(yīng)商 | |
| 153433-21-7 | 氰基(羥基亞氨基)醋酸乙酯基-O2]三-1-吡咯烷基鏻六氟磷酸鹽 | [Ethyl cyano(hydroxyimino)acetato-O2]tri-1-pyrrolidinylphosphonium hexafluorophosphate; PyOxim | 無 | C17H29N5O3P.PF6 | 詳情 | 供應(yīng)商 |